Müller cell proliferation and migration (MCPM)

Müller cell proliferation and migration is a complex biological process rather than a single molecular target. Müller cells are the primary macroglial cells in the vertebrate retina, providing essential physiological support, including neurotransmitter recycling, ion homeostasis, and metabolic regulation (PMID: 25732101). In response to retinal injury or disease, these cells undergo a process known as reactive gliosis, which involves morphological changes, the upregulation of intermediate filaments like GFAP, and significant increases in proliferation and migration (PMID: 15721723). While initially neuroprotective, chronic or excessive Müller cell proliferation and migration are central to the pathogenesis of several blinding diseases. In proliferative vitreoretinopathy (PVR), activated Müller cells migrate into the vitreous or subretinal space to form epiretinal membranes, leading to tractional retinal detachment (PMID: 23603460). Pharmacological intervention typically focuses on inhibiting the signaling cascades—such as the TGF-beta, PDGF, and VEGF pathways—that drive this glial response. Understanding the balance between the protective and destructive roles of Müller cell activity remains a critical challenge for developing targeted retinal therapies (PMID: 19163013).

Other names

Müller glial activationReactive retinal gliosisMüller cell gliosisRetinal glial proliferation

Drugs targeting this process typically act by inhibiting mitogenic signaling pathways (e.g., MAPK/ERK, PI3K/Akt), suppressing inflammatory cytokine production (e.g., TNF-alpha, IL-6), or antagonizing growth factors like VEGF and PDGF that drive glial activation.